New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Guardion Health Sciences, Inc.
GHSI
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

4M

Drug Manufacturers - Specialty & Generic

Next Earning date - 11 Nov 2024

4M

Drug Manufacturers - Specialty & Generic

Next Earning date - 11 Nov 2024

3.25USD
0.00 ( 0.00%)
favorite-chart

Relative Strenght

88
favorite-chart

Volume Buzz

-23%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

82%

Quote Panel

Shape
Updated October 15, 2024
1W -0.61 % 1M -37.38 % 3M -38.10 % 1Y -5.25 %

Key Metrics

Shape
  • Market Cap

    4.39M


  • Shares Outstanding

    1.35M


  • Share in Float

    1.16M


  • Dividende

    20


  • Earning Date

    11 Nov 2024


  • Price Target

    3.25


  • Average Volume

    117004


  • Beta

    0.708


  • Range

    3.04-18.0


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.guardionhealth.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.47x

P/S Ratio

0.30x

P/B Ratio

0.0

Debt/Equity

-62.9%

Net Margin

$-4.1

EPS

How GHSI compares to sector?

P/E Ratio

Relative Strength

Shape

GHSI

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$15M

Shape20190%

2025-Revenue

$1.02

Shape32%

2025-EPS

$9M

Shape-588%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Maxim Group

initialise

Previous: Not converted

2022-03-09

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-1.50
vs -6.00

Q4.22

arrow
arrow

N/A

NA
vs NA

Q1.23

arrow
arrow

+200%

5
vs -5.00

Q2.23

arrow
arrow

N/A

-0.93
vs -1.50

Q3.23

arrow
arrow

+119%

0.29
vs -1.50

Q4.23

arrow
arrow

N/A

0.33
vs NA

Q1.24

arrow
arrow

N/A

NA
vs 5

Q2.24

arrow
arrow

N/A

-1.64
vs -0.93

Q3.24

arrow
arrow

N/A

-0.58
vs 0.29

Q4.24

arrow
arrow

N/A

-0.28
vs 0.33

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-15%

2.7M  vs 3.1M

Q4.22

arrow
arrow

+4%

2.7M  vs 2.6M

Q1.23

arrow
arrow

+34%

3.2M  vs 2.4M

Q2.23

arrow
arrow

-15%

2.8M  vs 3.3M

Q3.23

arrow
arrow

+25%

3.3M  vs 2.7M

Q4.23

arrow
arrow

+8%

2.9M  vs 2.7M

Q1.24

arrow
arrow

-6%

3M  vs 3.2M

Q2.24

arrow
arrow

-97%

72.9K  vs 2.8M

Q3.24

arrow
arrow

+5%

3.5M  vs 3.3M

Q4.24

arrow
arrow

+23%

3.6M  vs 2.9M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-6%

-0.06
vs -0.06

Q4.22

arrow
arrow

-184%

-1.84
vs -0.06

Q1.23

arrow
arrow

+30%

0.3
vs -1.84

Q2.23

arrow
arrow

-16%

-0.16
vs 0.3

Q3.23

arrow
arrow

+5%

0.05
vs -0.16

Q4.23

arrow
arrow

+5%

0.05
vs 0.05

Q1.24

arrow
arrow

-139%

-1.39
vs 0.05

Q2.24

arrow
arrow

-14%

-0.14
vs -1.39

Institutionnal OwnershipShape

status-upQoQ

Q2.19

arrow
arrow

3

3
vs NA

NA

Q3.19

arrow
arrow

4

4
vs 3

33%

Q4.19

arrow
arrow

9

9
vs 4

125%

Q1.20

arrow
arrow

11

11
vs 9

22%

Q2.20

arrow
arrow

17

17
vs 11

55%

Q3.20

arrow
arrow

14

14
vs 17

-18%

Q4.20

arrow
arrow

17

17
vs 14

21%

Q4.21

arrow
arrow

1

1
vs NA

NA

Earnings Growth

Latest News

GHSI

globenewswire.com

17 hours ago